Is it the right moment to include hyperthermic intraperitoneal chemotherapy as standard in ovarian cancer management? A reappraisal. [electronic resource]
Producer: 20190820Description: 19-23 p. digitalISSN:- 1107-0625
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chemotherapy, Cancer, Regional Perfusion -- mortality
- Combined Modality Therapy
- Cytoreduction Surgical Procedures -- mortality
- Disease Management
- Disease-Free Survival
- Female
- Humans
- Hyperthermia, Induced -- mortality
- Ovarian Neoplasms -- pathology
- Survival Rate
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.